Lucid Diagnostics Inc. (LUCD) Earnings History
Annual and quarterly earnings data from 2018 to 2024
Loading earnings history...
LUCD EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
LUCD Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | -90.2% | -1059.6% | -1047.6% |
| 2023 | -249.2% | -1996.8% | -2169.1% |
| 2022 | -858.6% | -14899.5% | -14899.5% |
| 2021 | -17.0% | -5483.8% | -5615.6% |
| 2020 | - | - | - |
Download Data
Export LUCD earnings history in CSV or JSON format
Free sign-in required to download data
Lucid Diagnostics Inc. (LUCD) Earnings Overview
As of May 8, 2026, Lucid Diagnostics Inc. (LUCD) reported trailing twelve-month net income of -$10.44B, reflecting +16.7% year-over-year growth. The company earned $-96.51 per diluted share over the past four quarters, with a net profit margin of -1047.6%.
Looking at the long-term picture, LUCD's historical earnings data spans multiple years. The company achieved its highest annual net income of -$1M in fiscal 2018.
Lucid Diagnostics Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including GKOS (-$189M net income, -37.0% margin), NVCR (-$173M net income, -20.8% margin), NNOX (-$56M net income, -474.3% margin), LUCD has room to improve margins relative to the peer group. Compare LUCD vs GKOS →
LUCD Earnings vs Peers
Earnings metrics vs comparable public companies
LUCD Historical Earnings Data (2018–2024)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$46M | +13.6% | -$46M | $-1.05 | -1047.6% | -1059.6% |
| 2023 | -$53M | +6.2% | -$48M | $-1.26 | -2169.1% | -1996.8% |
| 2022 | -$56M | -100.1% | -$56M | $-1.55 | -14899.5% | -14899.5% |
| 2021 | -$28M | -239.1% | -$27M | $-0.78 | -5615.6% | -5483.8% |
| 2020 | -$8M | -87.3% | -$8M | $-0.22 | - | - |
| 2019 | -$4M | -292.6% | -$4M | $-0.12 | - | - |
| 2018 | -$1M | - | -$1M | $-0.03 | - | - |
See LUCD's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs LUCD Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare LUCD vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonLUCD — Frequently Asked Questions
Quick answers to the most common questions about buying LUCD stock.
Is LUCD growing earnings?
LUCD EPS is $-96.51, with earnings growth accelerating to +16.7%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-10.4B.
What are LUCD's profit margins?
Lucid Diagnostics Inc. net margin is -1047.6%, with operating margin at -1059.6%. Below-average margins reflect competitive or cost pressures.
How consistent are LUCD's earnings?
LUCD earnings data spans 2018-2024. The accelerating earnings trend is +16.7% YoY. Historical data enables comparison across business cycles.